Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA
MedTech
GE HealthCare's PET agent Vizamyl expands reach in Alzheimer's
The imaging agent can be used to deliver quantitative assessments such as calculations of amyloid prevalence through FDA-authorized software.
Conor Hale
Jun 27, 2025 9:45am
Incyte, FDA, Sun Pharma and more—Chutes & Ladders
Jun 27, 2025 8:30am
FDA amplifies Medtronic recall of Bravo acid reflux test capsule
Jun 26, 2025 10:33am
FDA moves to block Olympus endoscope imports
Jun 25, 2025 12:05pm
Minovia skates SPAC-wards into public market
Jun 25, 2025 10:33am
Cash-strapped Sangamo seeks partner for new gene therapy
Jun 24, 2025 11:53am
